Shares of RedHill Biopharma Ltd – (NASDAQ:RDHL) rose 13.8% during mid-day trading on Monday . The stock traded as high as $14.95 and last traded at $14.94, with a volume of 158,449 shares traded. The stock had previously closed at $13.13.

RDHL has been the topic of several analyst reports. Zacks Investment Research lowered RedHill Biopharma Ltd – from a “hold” rating to a “sell” rating in a report on Friday. FBR & Co reiterated a “buy” rating on shares of RedHill Biopharma Ltd – in a report on Wednesday, April 13th. Two research analysts have rated the stock with a sell rating and six have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $26.00.

The firm’s market cap is $185.28 million. The firm has a 50-day moving average price of $11.18 and a 200 day moving average price of $11.09.

RedHill Biopharma Ltd – (NASDAQ:RDHL) last issued its quarterly earnings results on Wednesday, July 27th. The company reported ($0.06) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.58) by $0.52. On average, analysts forecast that RedHill Biopharma Ltd – will post ($1.95) EPS for the current year.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.